XML 40 R29.htm IDEA: XBRL DOCUMENT v3.10.0.1
Business Segment and Geographical Information (Tables)
 9 Months Ended
Sep. 29, 2018
Segment Reporting [Abstract]  
Schedule of Segment Reporting Information, by Segment [Table Text Block]
Business Segment Information
 
 
Three Months Ended
 
Nine Months Ended
 
 
September 29,

 
September 30,

 
September 29,

 
September 30,

(In millions)
 
2018

 
2017

 
2018

 
2017

 
 
 
 
 
 
 
 
 
Revenues
 
 
 
 
 
 
 
 
Life Sciences Solutions
 
$
1,504

 
$
1,382

 
$
4,572

 
$
4,150

Analytical Instruments
 
1,333

 
1,189

 
3,901

 
3,407

Specialty Diagnostics
 
894

 
844

 
2,773

 
2,572

Laboratory Products and Services
 
2,470

 
1,933

 
7,433

 
5,424

Eliminations
 
(281
)
 
(232
)
 
(828
)
 
(682
)
 
 
 
 
 
 
 
 
 
Consolidated revenues
 
5,920

 
5,116

 
17,851

 
14,871

 
 
 
 
 
 
 
 
 
Segment Income (a)
 
 
 
 
 
 
 
 
Life Sciences Solutions
 
495

 
452

 
1,534

 
1,333

Analytical Instruments
 
294

 
257

 
831

 
681

Specialty Diagnostics
 
223

 
218

 
719

 
685

Laboratory Products and Services
 
299

 
243

 
916

 
704

 
 
 
 
 
 
 
 
 
Subtotal reportable segments (a)
 
1,311

 
1,170

 
4,000

 
3,403

 
 
 
 
 
 
 
 
 
Cost of revenues credits (charges), net
 
1

 
(45
)
 
(7
)
 
(77
)
Selling, general and administrative credits (charges), net
 
4

 
(37
)
 
(7
)
 
(75
)
Restructuring and other income (costs), net
 
27

 
(49
)
 
(35
)
 
(95
)
Amortization of acquisition-related intangible assets
 
(431
)
 
(405
)
 
(1,316
)
 
(1,153
)
 
 
 
 
 
 
 
 
 
Consolidated operating income
 
912

 
634

 
2,635

 
2,003

Other expense, net (b)
 
(102
)
 
(154
)
 
(385
)
 
(394
)
 
 
 
 
 
 
 
 
 
Income from continuing operations before income taxes
 
$
810

 
$
480

 
$
2,250

 
$
1,609

 
 
 
 
 
 
 
 
 
Depreciation
 
 
 
 
 
 
 
 
Life Sciences Solutions
 
$
29

 
$
32

 
$
89

 
$
97

Analytical Instruments
 
18

 
17

 
53

 
51

Specialty Diagnostics
 
19

 
19

 
56

 
54

Laboratory Products and Services
 
66

 
44

 
195

 
104

 
 
 
 
 
 
 
 
 
Consolidated depreciation
 
$
132

 
$
112

 
$
393

 
$
306

(a)
Represents operating income before certain charges to cost of revenues and selling, general and administrative expenses; restructuring and other costs, net; and amortization of acquisition-related intangibles.
(b)
The company does not allocate other expense, net to its segments.
Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table Text Block]
Business Segment Information
 
 
Three Months Ended
 
Nine Months Ended
 
 
September 29,

 
September 30,

 
September 29,

 
September 30,

(In millions)
 
2018

 
2017

 
2018

 
2017

 
 
 
 
 
 
 
 
 
Revenues
 
 
 
 
 
 
 
 
Life Sciences Solutions
 
$
1,504

 
$
1,382

 
$
4,572

 
$
4,150

Analytical Instruments
 
1,333

 
1,189

 
3,901

 
3,407

Specialty Diagnostics
 
894

 
844

 
2,773

 
2,572

Laboratory Products and Services
 
2,470

 
1,933

 
7,433

 
5,424

Eliminations
 
(281
)
 
(232
)
 
(828
)
 
(682
)
 
 
 
 
 
 
 
 
 
Consolidated revenues
 
5,920

 
5,116

 
17,851

 
14,871

 
 
 
 
 
 
 
 
 
Segment Income (a)
 
 
 
 
 
 
 
 
Life Sciences Solutions
 
495

 
452

 
1,534

 
1,333

Analytical Instruments
 
294

 
257

 
831

 
681

Specialty Diagnostics
 
223

 
218

 
719

 
685

Laboratory Products and Services
 
299

 
243

 
916

 
704

 
 
 
 
 
 
 
 
 
Subtotal reportable segments (a)
 
1,311

 
1,170

 
4,000

 
3,403

 
 
 
 
 
 
 
 
 
Cost of revenues credits (charges), net
 
1

 
(45
)
 
(7
)
 
(77
)
Selling, general and administrative credits (charges), net
 
4

 
(37
)
 
(7
)
 
(75
)
Restructuring and other income (costs), net
 
27

 
(49
)
 
(35
)
 
(95
)
Amortization of acquisition-related intangible assets
 
(431
)
 
(405
)
 
(1,316
)
 
(1,153
)
 
 
 
 
 
 
 
 
 
Consolidated operating income
 
912

 
634

 
2,635

 
2,003

Other expense, net (b)
 
(102
)
 
(154
)
 
(385
)
 
(394
)
 
 
 
 
 
 
 
 
 
Income from continuing operations before income taxes
 
$
810

 
$
480

 
$
2,250

 
$
1,609

 
 
 
 
 
 
 
 
 
Depreciation
 
 
 
 
 
 
 
 
Life Sciences Solutions
 
$
29

 
$
32

 
$
89

 
$
97

Analytical Instruments
 
18

 
17

 
53

 
51

Specialty Diagnostics
 
19

 
19

 
56

 
54

Laboratory Products and Services
 
66

 
44

 
195

 
104

 
 
 
 
 
 
 
 
 
Consolidated depreciation
 
$
132

 
$
112

 
$
393

 
$
306

(a)
Represents operating income before certain charges to cost of revenues and selling, general and administrative expenses; restructuring and other costs, net; and amortization of acquisition-related intangibles.
(b)
The company does not allocate other expense, net to its segments.
Schedule of Revenue from External Customers and Long-Lived Assets, by Geographical Areas [Table Text Block]
Geographical Information
 
 
Three Months Ended
 
Nine Months Ended
 
 
September 29,

 
September 30,

 
September 29,

 
September 30,

(In millions)
 
2018

 
2017

 
2018

 
2017

 
 
 
 
 
 
 
 
 
Revenues (c)
 
 
 
 
 
 
 
 
United States
 
$
2,918

 
$
2,454

 
$
8,588

 
$
7,315

China
 
629

 
523

 
1,818

 
1,476

Other
 
2,373

 
2,139

 
7,445

 
6,080

 
 
 
 
 
 
 
 
 
Consolidated revenues
 
$
5,920

 
$
5,116

 
$
17,851

 
$
14,871

(c)
Revenues are attributed to countries based on customer location.